NIM
Northeast Investment Management Portfolio holdings
AUM
$2.34B
This Quarter Return
+2.33%
1 Year Return
+18.21%
3 Year Return
+90.52%
5 Year Return
+146.85%
10 Year Return
+366.16%
AUM
$994M
AUM Growth
+$994M
(+2.2%)
Cap. Flow
+$4.83M
Cap. Flow
% of AUM
0.49%
Top 10 Holdings %
Top 10 Hldgs %
27.23%
Holding
159
New
6
Increased
57
Reduced
70
Closed
4
Top Buys
| 1 |
Thermo Fisher Scientific
TMO
|
$4.26M |
| 2 |
Church & Dwight Co
CHD
|
$2.17M |
| 3 |
Bristol-Myers Squibb
BMY
|
$2.1M |
| 4 |
Meta Platforms (Facebook)
META
|
$2.01M |
| 5 |
Starbucks
SBUX
|
$1.95M |
Top Sells
| 1 |
Novartis
NVS
|
$4.69M |
| 2 |
Stifel
SF
|
$2.6M |
| 3 |
Abbott
ABT
|
$1.98M |
| 4 |
Novo Nordisk
NVO
|
$1.88M |
| 5 |
Walt Disney
DIS
|
$1.35M |
Sector Composition
| 1 | Healthcare | 17.49% |
| 2 | Financials | 12.74% |
| 3 | Industrials | 12.38% |
| 4 | Consumer Discretionary | 10.08% |
| 5 | Technology | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Visa
V
$683B
| $32M | 3.22% | 431,417 -10,109 | -2% | -$750K |
|
|
2
Walt Disney
DIS
$213B
| $30.9M | 3.11% | 315,975 -13,798 | -4% | -$1.35M |
|
3
Johnson & Johnson
JNJ
$427B
| $30.2M | 3.04% | 248,886 +1,333 | +0.5% | +$162K |
|
4
Apple
AAPL
$3.45T
| $28.3M | 2.85% | 296,178 -4,756 | -2% | -$455K |
|
5
CVS Health
CVS
$92.8B
| $28.1M | 2.83% | 293,425 -5,226 | -2% | -$500K |
|
6
GE Aerospace
GE
$292B
| $26.6M | 2.68% | 845,272 -6,952 | -0.8% | -$219K |
|
7
Berkshire Hathaway Class B
BRK.B
$1.09T
| $24.8M | 2.5% | 171,416 -1,523 | -0.9% | -$221K |
|
8
Union Pacific
UNP
$133B
| $23.9M | 2.41% | 274,252 -2,448 | -0.9% | -$214K |
|
9
Exxon Mobil
XOM
$487B
| $23.2M | 2.33% | 247,266 +3,987 | +2% | +$374K |
|
10
3M
MMM
$82.8B
| $22.7M | 2.29% | 129,828 -826 | -0.6% | -$145K |
|
11
Alphabet (Google) Class A
GOOGL
$2.57T
| $22.5M | 2.26% | 31,910 +363 | +1% | +$255K |
|
12
Honeywell
HON
$139B
| $22.4M | 2.26% | 192,968 +3,672 | +2% | +$427K |
|
13
Amazon
AMZN
$2.44T
| $22.1M | 2.23% | 30,919 +1,507 | +5% | +$1.08M |
|
14
Vanguard Real Estate ETF
VNQ
$34.6B
| $21.7M | 2.18% | 244,696 +5,036 | +2% | +$447K |
|
|
15
Meta Platforms (Facebook)
META
$1.86T
| $21.5M | 2.16% | 187,973 +17,594 | +10% | +$2.01M |
|
|
16
Bristol-Myers Squibb
BMY
$96B
| $20.6M | 2.07% | 279,765 +28,494 | +11% | +$2.1M |
|
17
Manhattan Associates
MANH
$13B
| $20.4M | 2.05% | 317,800 -9,639 | -3% | -$618K |
|
18
Gilead Sciences
GILD
$140B
| $20.2M | 2.03% | 242,199 -6,971 | -3% | -$582K |
|
19
Akamai
AKAM
$11.3B
| $19.8M | 1.99% | 354,493 -3,321 | -0.9% | -$186K |
|
20
American Tower
AMT
$95.5B
| $19.8M | 1.99% | 174,226 -1,851 | -1% | -$210K |
|
21
Vanguard Short-Term Corporate Bond ETF
VCSH
$35.4B
| $17.1M | 1.72% | 212,095 +1,021 | +0.5% | +$82.5K |
|
22
Chevron
CVX
$324B
| $16.5M | 1.65% | 156,961 +3,655 | +2% | +$383K |
|
23
Danaher
DHR
$147B
| $16.4M | 1.65% | 162,351 +6,924 | +4% | +$699K |
|
24
T Rowe Price
TROW
$23.6B
| $15.9M | 1.6% | 217,373 -3,562 | -2% | -$260K |
|
25
Schlumberger
SLB
$55B
| $15.5M | 1.56% | 196,230 +4,795 | +3% | +$379K |
|